The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader
The primary objective of the study is to assess the safety and tolerability of SUVN-I6107 by monitoring adverse events (AEs), clinical laboratory, vital signs and electrocardiographs
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
SPARC to receive 55% equity in Tiller Therapeutics
Biocon Biologics is among the two pharmaceutical companies from India in the 93 companies featuring on the Asia IP Elite 2024 list
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Subscribe To Our Newsletter & Stay Updated
